PCM
OPTN

Penserra Capital Management’s OptiNose OPTN Stock Holding History

Penserra Capital Management’s Portfolio OPTN Stock Details OPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-29
Closed -$1K – 1102
2020
Q3 		$1K Buy
+29
New +$2.15K ﹤0.01% 924

Other funds holding OPTN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
SW
SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Penserra Capital Management's OPTN Position: Q4 2020 in Review

Penserra Capital Management sold out of OptiNose (OPTN) in Q4 2020, closing a stake of 29 shares — an estimated $1K sold.

Penserra Capital Management first reported a position in OPTN in Q3 2020 and held it in 1 quarter. The position peaked at $1K in Q3 2020. 67 funds tracked by Wall St. Rank hold OPTN as of Q4 2020.

  • Penserra Capital Management reported no remaining OptiNose position as of Q4 2020 after selling out during the quarter.
  • Penserra Capital Management sold 29 OptiNose shares in Q4 2020, an estimated $1K.
  • Penserra Capital Management first reported a position in OptiNose in Q3 2020 and held it in 1 quarter.
  • Penserra Capital Management's OptiNose position peaked at $1K in Q3 2020.
  • 67 funds tracked by Wall St. Rank held OptiNose as of Q4 2020.

Based on Penserra Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.